421 related articles for article (PubMed ID: 25241124)
1. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
[TBL] [Abstract][Full Text] [Related]
2. Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells.
Fehmann HC; Habener JF
Endocrinology; 1992 May; 130(5):2890-6. PubMed ID: 1374016
[TBL] [Abstract][Full Text] [Related]
3. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
4. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells.
Zhu ZQ; Wang D; Xiang D; Yuan YX; Wang Y
Metabolism; 2014 Jan; 63(1):120-6. PubMed ID: 24140090
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes.
Lamirand A; Pallud-Mothré S; Ramaugé M; Pierre M; Courtin F
Endocrinology; 2008 Jul; 149(7):3713-21. PubMed ID: 18420745
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
8. Interaction of glucagon-like peptide-I (7-37) and somatostatin-14 on signal transduction and proinsulin gene expression in beta TC-1 cells.
Fehmann HC; Strowski M; Göke B
Metabolism; 1994 Jun; 43(6):787-92. PubMed ID: 7911222
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
Hui H; Nourparvar A; Zhao X; Perfetti R
Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
[TBL] [Abstract][Full Text] [Related]
10. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
Waeber G; Thompson N; Waeber B; Brunner HR; Nicod P; Grouzmann E
Endocrinology; 1993 Sep; 133(3):1061-7. PubMed ID: 8396008
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
Friedrichsen BN; Neubauer N; Lee YC; Gram VK; Blume N; Petersen JS; Nielsen JH; Møldrup A
J Endocrinol; 2006 Mar; 188(3):481-92. PubMed ID: 16522728
[TBL] [Abstract][Full Text] [Related]
13. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.
Islam D; Zhang N; Wang P; Li H; Brubaker PL; Gaisano HY; Wang Q; Jin T
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E174-81. PubMed ID: 18854429
[TBL] [Abstract][Full Text] [Related]
14. β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells.
Dentice M; Luongo C; Ambrosio R; Sibilio A; Casillo A; Iaccarino A; Troncone G; Fenzi G; Larsen PR; Salvatore D
Gastroenterology; 2012 Oct; 143(4):1037-47. PubMed ID: 22771508
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
Skoglund G; Hussain MA; Holz GG
Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
[TBL] [Abstract][Full Text] [Related]
16. Regulation of brain insulin mRNA by glucose and glucagon-like peptide 1.
Madadi G; Dalvi PS; Belsham DD
Biochem Biophys Res Commun; 2008 Nov; 376(4):694-9. PubMed ID: 18809381
[TBL] [Abstract][Full Text] [Related]
17. Homologous desensitization of the insulinotropic glucagon-like peptide-I (7-37) receptor on insulinoma (HIT-T15) cells.
Fehmann HC; Habener JF
Endocrinology; 1991 Jun; 128(6):2880-8. PubMed ID: 1645253
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.
MacDonald PE; Wang X; Xia F; El-kholy W; Targonsky ED; Tsushima RG; Wheeler MB
J Biol Chem; 2003 Dec; 278(52):52446-53. PubMed ID: 14565957
[TBL] [Abstract][Full Text] [Related]
20. Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue.
Baden MY; Fukui K; Hosokawa Y; Iwahashi H; Imagawa A; Shimomura I
PLoS One; 2015; 10(12):e0144606. PubMed ID: 26659307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]